Does Rallies show Form 4 insider transactions for COEP?

Yes. Rallies tracks COEP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is COEP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for COEP. It does not provide personalized investment advice.

COEP (Coeptis Therapeutics Holdings Inc. Common Stock) Stock Analysis - Insider Trades

Coeptis Therapeutics Holdings Inc. Common Stock (COEP) is a publicly traded Healthcare sector company. As of May 21, 2026, COEP trades at $16.40 with a market cap of $102.06M and a P/E ratio of -6.51. COEP moved +1.05% today. Year to date, COEP is +6.49%; over the trailing twelve months it is +31.52%. Its 52-week range spans $2.31 to $21.41. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces COEP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading COEP stock inside the company?

Recent COEP insider activity includes DeSilva Tara bought 466, DeSilva Tara bought 1.80K, Cogley Brian bought 5.00K, Mehalick David bought 6.00K, and Mehalick David bought 14.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

COEP Key Metrics

Key financial metrics for COEP
Metric	Value
Price	$16.40
Market Cap	$102.06M
P/E Ratio	-6.51
EPS	$-2.52
Dividend Yield	0.00%
52-Week High	$21.41
52-Week Low	$2.31
Volume	111.93K
Avg Volume	0
Revenue (TTM)	$1.41M
Net Income	$-12.93M
Gross Margin	87.22%

Recent COEP Insider Trades

DeSilva Tara bought 466 (~$260.96) on Jan 12, 2024.
DeSilva Tara bought 1.80K (~$1.04K) on Jan 12, 2024.
Cogley Brian bought 5.00K (~$3.35K) on Jan 10, 2024.
Mehalick David bought 6.00K (~$4.02K) on Jan 8, 2024.
Mehalick David bought 14.00K (~$9.24K) on Jan 8, 2024.

Latest COEP News

Z Squared Merges with Coeptis, Lists 51.5 Million Shares on Nasdaq on April 27 — Apr 24, 2026
Nasdaq Approves Listing for Post-Merger Coeptis Stock, Merger Expected Q2 2026 — Apr 7, 2026

COEP Analyst Consensus

1 analysts cover COEP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.

Common questions about COEP

Who is trading COEP stock inside the company?: Recent COEP insider activity includes DeSilva Tara bought 466, DeSilva Tara bought 1.80K, Cogley Brian bought 5.00K, Mehalick David bought 6.00K, and Mehalick David bought 14.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for COEP?: Yes. Rallies tracks COEP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is COEP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for COEP. It does not provide personalized investment advice.